- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05815537
Development of Functional Spatial Hearing in Reverberation
March 1, 2024 updated by: Ellen Peng, Father Flanagan's Boys' Home
The goal of the clinical trial study (Phase 0) is to map out the developmental trajectory of functional spatial hearing abilities in reverberant environments for children with normal hearing between the ages of 6 and 18 years, and to understand the inter-relationships between the three perceptual abilities: auditory object size formation, spatial acuity, and spatial unmasking during typical development.
Children are asked to perform psychoacoustic tasks when the auditory stimuli are processed to present in virtual acoustic environments (1) with no reverberation and (2) with one of the two levels of reverberation that emulate everyday indoor environments.
The intervention of this clinical study is in the random assignment of one of the two reverberant environments.
Researchers will compare these children with a group of normal-hearing adults to anchor matured performances.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Z. Ellen Peng, PhD
- Phone Number: 531-355-6975
- Email: ellen.peng@boystown.org
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68131
- Recruiting
- Boys Town National Research Hospital
-
Contact:
- Z. Ellen Peng, PhD
- Phone Number: 531-355-6975
- Email: ellen.peng@boystown.org
-
Principal Investigator:
- Z. Ellen Peng, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- All individuals within age limits who are typically developing with normal hearing who pass 25 dB HL from 250 Hz to 8000 Hz.
Exclusion Criteria:
- Individuals who fail hearing screen as described above.
- Individuals who have a diagnosed intellectual developmental disability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low-Reverberation
Participants perform psychoacoustic tasks under a low-reverberant environment and a control environment without reverberation.
|
The exposure to low-reverberation is by presenting auditory stimuli to participants that are digitally processed to contain auditory cues that sound more or less reverberant, e.g., small classroom.
|
Experimental: High-Reverberation
Participants perform psychoacoustic tasks under a high-reverberant environment and a control environment without reverberation.
|
The exposure to high-reverberation is by presenting auditory stimuli to participants that are digitally processed to contain auditory cues that sound more or less reverberant, e.g., large lecture hall/auditorium.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Auditory Object Size (Apparent Source Width)
Time Frame: Year 1-3
|
Psychoacoustic measure of the smallest detectable change in width of an auditory image in degree angular span in the horizontal plane
|
Year 1-3
|
Spatial Acuity (Minimum audible angle)
Time Frame: Year 1-3
|
Psychoacoustic measure of the smallest detectable angular separation between two auditory objects
|
Year 1-3
|
Spatial Unmasking (Minimum angular separation)
Time Frame: Year 1-3
|
Psychoacoustic measure of the smallest angular separation to gain a target speech benefit in the presence of distracting speech maskers
|
Year 1-3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Z. Ellen Peng, Father Flanagan's Boys' Home
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Estimated)
June 30, 2025
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
April 4, 2023
First Submitted That Met QC Criteria
April 4, 2023
First Posted (Actual)
April 18, 2023
Study Record Updates
Last Update Posted (Estimated)
March 4, 2024
Last Update Submitted That Met QC Criteria
March 1, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- BoysTown
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spatial Hearing Development
-
University of South FloridaNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingAging | Hearing Impairment, Sensorineural | Spatial Perception | Hearing AidsUnited States
-
Rambam Health Care CampusCompleted
-
Çankırı Karatekin UniversityCompleted
-
Sonova AGSwiss Commission for Technology and InnovationCompletedAbility, SpatialSwitzerland
-
Sonova AGSwiss Commission for Technology and InnovationCompletedAbility, SpatialSwitzerland
-
Sonova AGSwiss Commission for Technology and InnovationCompletedAbility, SpatialSwitzerland
-
German Center for Neurodegenerative Diseases (DZNE)CompletedBalance | Spatial OrientationGermany
-
Children's Hospital Medical Center, CincinnatiRecruitingHearing Loss, Bilateral | Language DevelopmentUnited States
-
Rutgers, The State University of New JerseyRecruitingSpatial NavigationUnited States
-
Sheba Medical CenterBar-Ilan University, IsraelUnknown
Clinical Trials on Low-Reverberation
-
Sonova AGCompleted
-
Temple UniversityInternational Life Sciences InstituteCompleted
-
Iladevi Cataract and IOL Research CenterCompleted
-
Vanderbilt UniversityTerminatedChronic Kidney DiseaseUnited States
-
University of ChicagoCompleted
-
VA Office of Research and DevelopmentCompletedCentral Vision Loss From Macular DiseasesUnited States
-
University of NebraskaCompletedChronic DiseaseUnited States
-
Taipei Veterans General Hospital, TaiwanRecruiting
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brigham...Completed